|
The Journal of Lipid Research, Vol. 39, 2293-2299, November 1998
Copyright © 1998 by Lipid Research, Inc.
Optimization of the assay for sialic acid determination in low density lipoprotein
Igor A. Sobenina,
Vladimir V. Tertova, and
Alexander N. Orekhova
a Institute of Experimental Cardiology, Russian Cardiology Research Center, Moscow, and Institute for Atherosclerosis Research, Ltd., Moscow, Russia
Correspondence to:
Igor A. Sobenin.
Sialic acid level in blood plasma and circulating glycoproteins is considered to be a marker for a number of pathologic conditions, including atherosclerosis, cancer, etc. The precise measurement of sialic acid level is an important laboratory procedure to allow correct interpretation of results. Colorimetric methods commonly used for the measurement of sialic acid are not highly specific, as interfering substances may alter the results. Among these, malondialdehyde and other aldehydes play the decisive role. In the circulation, aldehydes are commonly produced during lipid peroxidation in the lipid core of lipoprotein particles, especially low density lipoprotein (LDL). To establish the impairment to the sialic acid determination in LDL introduced by interfering substances, the optimized assay based on Warren's traditional method was developed and tested in 606 LDL samples. The optimization implies the comparison of color developed using the standard Warren procedure with that due to contaminating agents, mainly thiobarbituric acid-reactive substances (TBARS). In LDL stored at 4°C, the estimates obtained by the modified procedure were 41.5% or 30.1 nmol/mg lower, on average, compared to the standard procedure (n = 45, P < 0.0001). Even in LDL stored at -70°C, sialic acid estimates obtained by the modified procedure were 6.6% or 3.6 nmol/mg lower, on average, compared to the standard measurement (n = 561, P < 0.005). Thus, the modified procedure avoids significant distortion of the measurement induced by the presence of interfering agents.Sobenin, I. A., V. V. Tertov, and A. N. Orekhov. Optimization of the assay for sialic acid determination in low density lipoprotein. J. Lipid Res. 1998. 39: 22932299.
Supplementary key words:
low density lipoprotein, sialic acid measurement, thiobarbituric acid, resorcinol

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. I. van Kasteren, S. J. Campbell, S. Serres, D. C. Anthony, N. R. Sibson, and B. G. Davis
Glyconanoparticles allow pre-symptomatic in vivo imaging of brain disease
PNAS,
January 6, 2009;
106(1):
18 - 23.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Garner, D. J. Harvey, L. Royle, M. Frischmann, F. Nigon, M. J. Chapman, and P. M. Rudd
Characterization of human apolipoprotein B100 oligosaccharides in LDL subfractions derived from normal and hyperlipidemic plasma: deficiency of {alpha}-N-acetylneuraminyllactosyl-ceramide in light and small dense LDL particles
Glycobiology,
October 1, 2001;
11(10):
791 - 802.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Garner, A. H. Merry, L. Royle, D. J. Harvey, P. M. Rudd, and J. Thillet
Structural Elucidation of the N- and O-Glycans of Human Apolipoprotein(a). ROLE OF O-GLYCANS IN CONFERRING PROTEASE RESISTANCE
J. Biol. Chem.,
June 15, 2001;
276(25):
22200 - 22208.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|